An Alternative Approach to Low-Dose Buprenorphine Induction in Pregnancy and Postpartum

Area of Science:

• Obstetrics and Gynecology
• Addiction Medicine
• Neonatal Research

Background:

• Traditional opioid use disorder treatment requires significant withdrawal before medication initiation.
• Research on low-dose buprenorphine induction during pregnancy is limited.
• Opioid use disorder in pregnancy presents unique challenges for both mother and neonate.

Purpose of the Study:

• To evaluate obstetric and neonatal outcomes following low-dose buprenorphine induction.
• To assess the feasibility and safety of this induction method in pregnant individuals.
• To determine treatment retention rates in this population.

Main Methods:

• Retrospective case series design.
• Review of patients undergoing low-dose buprenorphine induction during pregnancy or postpartum.
• Data collection on obstetric and neonatal outcomes over a 3-year period at an urban academic medical center.

Main Results:

• Nine patients initiated low-dose buprenorphine induction.
• High treatment retention rate observed, with most patients completing induction.
• No apparent adverse neonatal events were associated with the treatment.
• Four patients achieved sustained remission and are parenting.

Conclusions:

• Low-dose buprenorphine induction appears to be an effective and safe option for pregnant individuals with opioid use disorder.
• The method demonstrates high treatment retention and positive neonatal outcomes.
• Further research is warranted to confirm these findings in larger cohorts.